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  The 
Development 
and 
Optimization of 
Processes For 
The Expression 
of Sialylated 
Recombinant 
Human 
Therapeutic 
Glycoprotein in 
Insect Cell-
Baculovirus 
System. 
 
 
Badarulhisam 
bin Abdul 
Rahman 
 
671211-06-
5005 
 
Product/process 
development 
(design end 
engineering) 
 
Human 
Pharmaceutical 
Products  
 
(S20604) 
 
Chemical 
Engineering  
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Development 
of 
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Products 
 
EA 
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3 years 
 
 
 
Table 2. – Continued 
GRANT REQUESTED YEAR 1 (2003) LIST OF MAJOR EQUIPMENTS REQUESTED Status Remark 
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& Contract 
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J400 
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Transportation 
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Rentals 
 
 
 
 
J600 
Research 
Materials & 
Supplies 
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Minor 
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& Repairs 
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Special 
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Equipments 
& 
Accessories 
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1 
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2 
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3 
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chromatography 
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CHAPTER 
1 
 
APPLICATION 
GUIDELINES AND FORMS 
 
 
A. PURPOSE 
 
Application Form  should be used for applying research grant under IRPA 
mechanism. 
 
 
B. INFORMATION REQIRED 
 
All application for IRPA research grant should be submitted using  the standard 
IRPA Application  Form.  Each form should consist only one project. 
 
 
C. RESPONSIBILITY 
 
Institution IRPA Coordinator is required to submit to MOSTE IRPA Secretariat 
one hard copy of application form together with the Institutional Summary 
Application in single  merge electronic  file in excel format. 
 
 
D. SUBMISSION PROCEDURE 
 
One copy  of the application form is to be mailed to: 
 
 
IRPA Secretariat  
Ministry of Science, Technology and the Environment  
Block C5, Parcel C 
Putrajaya 
 
 
 
 
 
 
 
 
 
A.     Programme/Project number (Please refer to the Guidelines) 
B. Programme title   Programme title  should be filled for Prioritised & Strategic research proposal only  and repeated in all 
application form for each project under the same programme. 
 
 
 
 
B1.    Project title (for Experimental Applied, Prioritised and Strategic research proposal) 
 
The Development and Optimization of Processes for the Expression of Sialylated 
Recombinant Human Therapeutic Glycoprotein in Insect Cell-Baculovirus System. 
 
C.     Project leader (Please indicate the name and identification number of the project leader) 
 
Name: Dr. Badarulhisam bin Abdul Rahman 
 
NRIC: 671211-06- 5005 
 
C1.   Programme  Head ( Prioritised & Strategic research proposal is required to fill this section and 
should  be repeated in all project under this programme) 
 
 
Name: 
 
NRIC: 
 
D.   Organisation (Please indicate the name, address, telephone and fax of the organisation in which the project leader is
based)  
 
          Bioprocess Engineering Department 
Faculty of Chemical and Natural Resources Engineering 
Universiti Teknologi Malaysia 
81310 UTM, Skudai. Johor 
E.   Key words (Please provide a maximum of 5 key words that describe the research of the project.  The key words will be 
incorporated in a database on Malaysian research)  
Therapeutic Product                         Metabolic engineering 
 
Insect Cell-Baculovirus                     Glycoprotein 
        
       Bioprocessing 
I. Project Identification 
A. Specific objective of the project (Please describe the measurable general and specific objectives of the project 
and define the expected results.  Use results-oriented wording with verbs such as "to define ...", "to determine ...", "to identify 
...") 
1) To determine the optimal parameters (culture conditions, transferases and sugar nucleotides 
content) for the expression of complete sialylation of recombinant human glycoprotein. 
2) To develop an optimal processing condition for the production of human like glycoprotein in an 
artificial system by the manipulation of metabolic engineering and process engineering approach. 
B. Research background of the project (Please indicate if the project is new, modified or extended.  Give a summary   
of your literature review to indicate the originality of the proposed research, and describe related research to assist in assessing 
the research rationale and the potential for success) 
 • Project status (please indicate) x New  Modification to  Extension of 
     previous 
project 
 existing project 
II. Objectives of the Project  
 • Literature review summary 
The completion of the human genome sequence is expected to increase the demand for effective treatment using protein-
based therapies (cancer, HIV, autoimmune disease, neuromuscular, organ rejection and allergic diseases).  Most human 
proteins, glycoproteins with ‘complex type’ oligosaccharide moieties attached to an asparagine residue, usually terminated 
with sialic acid, an important determinant for biological activity, solubility and blood circulation time.  Insect cells-baculovirus 
system, an excellent artificial systems for the expression of recombinant glycoproteins, offers a very promising alternative to 
the mammalian cell lines which suffer from high cost of operation, as well as slow growth and low yield.  Unfortunately the N-
glycan structure of the recombinant glycoprotein produced in insect cell culture is slightly different from the ones naturally 
produced in human, usually unsialylated and sometimes nongalactosylated, suggesting the nonexistence of several genes in 
insect cells. Metabolic engineering is one of the approaches to mimic the biosynthesis pathway that is naturally occurring in 
human. The used of stably transformed cells with human enzymes or co-infection with baculoviruses carrying mammalian β-
(1-4)galactosyltransferase (1) and human CMP-Neu5Ac sugar nucleotide (2) were able to push the pathway towards human-
like biosynthesis pathway.  The addition of nucleotide sugar precursor into culture media also influences the final 
oligosaccharide structure (3).  Apart from that, the existence of β-N-acetylglucosaminidase in native cell lines is believed to be 
another reason for the deviation from human glycoprotein synthesis pathways (4).  Recently, we have cloned, expressed and 
characterized three D. melanogaster genes for β-N-acetylglucosaminidase and the inhibition study of these enzymes is 
underway (5). Since the complete pathway involves several enzyme and sugar nucleotides biosynthesis, process optimization 
for the expression of sialylated (human-like) recombinant glycoprotein is to be carried out in this project, specifically 
integrating molecular biology and chemical engineering approach.  Missing enzymes will be introduced by means of metabolic 
engineering, in combination with viral co-expression, culturing condition and bioreactor design. Statistical approaches with the 
utilization of Response Surface Methodology and Taguchi Method will be applied to analyze several important parameters for 
this process. 
References: 
1. Ailor, E., Takahashi, Y., Tsukamoto, K. Masuda, B. Abdul-Rahman, D.L Jarvis, Y.C Lee and M. J Betenbaugh (2000).  N-
glycan patterns of human transferin produced in Trichoplusia ni insect cells:  effect of mammalian galactosyltransferase. 
Glycobiology 10, (8): 837-47.   
2. B. Abdul-Rahman, D.L Jarvis, Y.C Lee and M. J Betenbaugh β-1,4-Galactosyltransferase Activity in Native and Engineered 
Insect Cells Measured with Time-Resolved Eu3+-Fluorescence. Journal of Carbohydrate Research Sept 2002-In Press.   
3. Lawrence, S.M., K.A.Huddleson, L.R.Pitts, N.Nguyen, Y.C.Lee, and M.J betenbaugh.  Expression of the human N-
acetylneuraminic acid phosphate synthase gene with 2-keto-3-deoxy-D-glycero-D-galacto-nonionic acid biosynthetic ability. J 
Biol Chem 275 (23): 17869-77.   
4. Tomiya, N. E. Ailor, S.M .Lawrence, MJ Betenbaugh and YC Lee (2001).  Determination of nucleotides and sugar nucleotide 
involved in protein glycosylation by high-performance anion-exchange chromatography: sugar nucleotide contents in cultured 
insect cells and mammalian cells.  Anal Biochem 293(1): 129-37. 
5. B. Abdul-Rahman, D.L Jarvis, Y.C Lee, K Palter and M. J Betenbaugh. Cloning, Expression and Characterization of 
Drosophilla melanogaster β-N-Acetylglucosaminidases.  (Manuscript: in preparation). 
 
• Related research 
 
Project Title:  Evaluation of the Enzymes in the N-Glycosylation Pathways of Native and Genetically 
Engineered Insect Cells. 
 
The proposed project will be a continuation of this project.  Some stably transformed cell lines and 
baculoviruses carrying the genes for human transferin, (model protein), α(2-6) sialyltransferase and β-1-4 
galactosyltransferase are available (Gifts from Prof. Dr. Michael J. Betenbaugh of the Department of Chemical 
Engineering, Johns Hopkins University, Maryland, USA).  The work centered on the development of 
metabolic engineering approach to mimic human glycorprotein biosynthesis pathways in insect cell culture.  
Missing genes in cell lines were determined.  By using human genome (NCBI) and Drosophila genome 
(FlyBASE) databases, human and Drosophila transferases genes were incorporated into suitable cell lines and 
used for the expression of human transferin, a model human glycoprotein.  Human transferin was chosen for 
its simple biantennary oligosaccharide structure with terminal sialic acid.  The outputs of the project:  Total 7 
peer-reviewed papers are expected. 
1.  N-glycan Patterns of Human Transferrin Produced in Trichoplusia ni Insect Cells: Effect of mammalian β(1-4)galactosyltransferase.  
Journal of Glycobiology vol 10, no 8 pp 837-847, 2000. 
2.  Crocus sativus Lectin Recognizes Man3GlcNAc in the N-glycan Core Structure.  Journal of Biological Chemistry, vol 275, 35 Sept 1, 
pp 26772-26779, 2000. 
3.  Application of Lanthanide Fluorescence in Glycobiology.  Journal of Glycobiology,  vol 10,no 10, 2000, pp 1140 
4.  β-1,4-Galactosyltransferase Activity in Native and Engineered Insect Cells Measured with Time-Resolved Eu3+-Fluorescence.  Journal 
of Carbohydrate Research Sept 2002-In Press. 
5..  Determination of nucleotides and sugar nucleotide involved in protein glycosylation by high-performance anion-exchange 
chromatography: sugar nucleotide contents in cultured insect cells and mammalian cells.  Anal Biochem 293(1): 129-37, 2001. 
6.  Cloning, Expression and Characterization of Drosophilla melanogaster β-N-Acetylglucosaminidases.  (Manuscript: in preparation). 
7.  Exoglycosidases in Native and Genetically Engineered Trichoplusia ni, Snyder S2 and Sf9 Cell Lines- Activity towards natural and 
synthetic substrates. (Manuscript: in preparation). 
 
 
C.     Type of research (Please indicate the type of research, one only; see definition of terms in the Guidelines) 
  1. Scientific research (fundamental research) 
    
 X 2. Technology development (applied research) 
    
  3. Product/process development (design end engineering) 
    
  4. Social/policy research 
    D. Socio-economic objective being addressed by the project (Please identify the Sector, SEO Category 
and SEO  Group which most appropriately describe the main beneficiary of your proposed project. For definitions, please refer 
to the Guidelines. Refer to the R&D Priority Areas for RM8  document attached and the Malaysian R&D Classification System  
brochure for the  SEO Group  code) 
• Sector                                    Science and Engineering 
 
 
• SEO Category                       Natural Sciences, Technologies and Engineering (S 50100) 
 
• SEO Group and Code           Applied Sciences and Technologies (S50106)  
 
 
E. Target Area, Research Theme, Programme being addressed (Please identify the Target Area, 
Research Theme and Programme under which your proposed project falls.  Refer to the attached R&D Priority Areas for RM8.  
For definitions please refer to the Guidelines) 
• Target Area                            Pharmaceutical Products Resources (EA 30800) 
 
 
• Research Theme                   Development of Pharmaceutical Products 
 
 
• Research Theme Code         EA 30801 
 
 
• Programme                            None 
 
F. Fields of research (Please identify the two main FOR Categories, FOR Groups and FOR Areas which most 
appropriately describe the scientific discipline of your proposed project.  For definitions, please refer to the Guidelines.  Refer to 
the Malaysian R&D Classification System brochure for the FOR classification and codes) 
• Primary Field of Research 
 
− FOR Category                   Engineering Sciences (F10700) 
                                                        
 
− FOR Group and Code      Chemical Engineering (F10702) 
                                                        
 
− FOR Area                         Other Chemical Engineering 
 
 
• Secondary Field of Research 
 
− FOR Category                 Medical and Health Sciences (F11000) 
                                                       
 
− FOR Group and Code     Pharmaceutical Industry (F11012) 
 
− FOR Area                        Other Pharmaceutical Industry         
 
 
 
A. Direct customers/beneficiaries of the project (Please identify clearly the potential customers/beneficiaries 
of the research results and provide details of their relevance, eg, size, economic contribution, etc) 
1. Local Pharmaceutical industries  
eg:  Inno-Biotechnology 
             Cyberjaya, Selangor 
 
2. Academic communities 
 
3. Patients with rheumatoid arthritis, HIV infection, ulcerative colitis, sickle cell 
anemia and many others which requiring protein based therapeutics. 
B. Outputs expected from the project (Please refer to the list of outputs in the Guidelines and give further 
details) 
1. New processes will be developed (patentable) for the production of human-like 
recombinant glycoproteins for protein-based pharmaceutical.  
2. World-class facilities for a large-scale insect-cell expression system will be available locally. 
3. Experts in protein-based pharmaceuticals (PhD, MSc graduates) 
 
C. Technology transfer/diffusion approach (Please describe how the outputs of the project will be 
transferred to the direct beneficiaries/customers.  Please also state if the  project outputs are sustainable, ie, if they can be 
utilised without further external assistance) 
1. Journal Publications. 
2. Possibility of partnership with pharmaceutical industries. 
3. Metabolic engineering is a new area in biotechnology. This project is a platform for an 
international collaboration with scientist from highly developed countries (USA, Japan) 
D. Organisational outcomes expected (Please refer to the list of outcomes in the Guidelines and give further 
details) 
 
1. Experts in the field of Metabolic Engineering especially for recombinant therapeutic processing. 
       1 PhD, 2 MSc. students and several final year student theses.  
 
2. Patent right, intellectual property rights and royalty for the possible commercialization of process. 
 
3. Organization reputation and demands for consultancy services 
E. Sector/National impacts expected (Please refer to the list of impacts in the Guidelines and give further details)  
 
1. Local technology capable of producing recombinant therapeutics will generate wealth and savings 
on foreign exchange for the expensive pharmaceuticals. 
 
2. Linkages with international research institution, universities. 
III. Benefits of the Project 
A. Research organisations involved in the project (Please identify all research organisations collaborating in 
the project, and describe their role/contribution to the project) 
1. Department of Bioprocess Engineering, Faculty of Chemical and Natural Resources Engineering, 
UTM  
 
    Contributions: 
 
- Experimental design. 
 
- Data analyses. 
 
 
 
 
 
B. Industry linkages (Please identify any industry or end-user group involved in the project, and describe its 
role/contribution to the project) 
 
         Inno-Biotechnology 
         Cyberjaya, 
         Selangor. 
 
         The newly developed and optimized processes could further be tested and utilized for the production 
of recombinant human Erythropoietin at pilot and production scale. 
 
IV. Project Structure 
C. Project Team 
 
Name1 Organisation Man-months
2 on 
project 
Project Leader (Please provide name) 
 
Dr. Badarulhisam Abdul Rahman 
 
Department of Bioprocess 
Engineering, Faculty of 
Chemical and Natural 
Resources Engineering, 
Universiti Teknologi Malaysia 
 
 
 
           6.0 
Programme Head (Please provide name) 
 
 
 
 
 
 
 
 
 
Researchers (Please provide names or numbers of 
researchers) 
 
1.  Dr. Ani Idris 
 
2.  Dr. Azila Abd. Aziz 
 
 
3.  Prof. Dr. Michael Betenbaugh 
     (Research Consultant-see attached letter) 
 
 
Department of Bioprocess 
Engineering, Faculty of 
Chemical and Natural 
Resources Engineering, 
Universiti Teknologi Malaysia 
 
Chemical Engineering 
Johns Hopkins University 
Maryland USA. 
 
 
 
4.5 
 
4.5 
 
 
 
              0 
Support Staff (Please indicate how many) 
 
        2 persons 
 
 
To be appointed 
 
 
12 
Contract Staff (Please indicate how many) 
 
       1 person 
 
 
To be appointed 
 
 
35.75 
  Total 62.75 
                                                          
1 Please attach the curriculum vitae of key research personnel.  Please follow the format included in 
Appendix A.. 
2 Based on 24 man-days per month; please use the man-days per staff category included in the Staff Cost 
Estimation Form in Appendix D. 
A. Research methodology (Please describe the research methodology to be followed. Identify specialised 
equipment, facilities and infrastructure which are required for the project, and indicate which are new) 
1. Stably Transformed Cell Lines with Human β(1-2)-N-acetylglucosaminyltransferase II and β(1-
4)Galactosyltransferase from the known sequence in human database will be generated.  The 
genes will also be cloned into baculovirus vector together with α−2,3 sialyltransferase and CMP-
Neu5Ac following established procedures.  [Ref: Davies, A.H. 1994, Current Methods for 
Manipulating Baculovirus. Biotech (N.Y.) 12(1):47-50] 
 
2. Optimization experiments to induce sugar nucleotide expression in selected cell lines.  Optimal 
sugar concentration (N-acetylglucosamine, Galactose and Mannose and Mannosamine) will be 
evaluated.  Cellular sugar nucleotides content generated will be determined and the optimal 
feeding conditions will be used for the next experiment. Cellular sugar nucleotides content will be 
determined using an HPLC with CarboPAc PA1 column or CLC-ODS column. [Ref:  
Determination of nucleotides and sugar nucleotide involved in protein glycosylation by high-
performance anion-exchange chromatography: sugar nucleotide contents in cultured insect cells 
and mammalian cells.  Anal Biochem 293(1): 129-37, 2001] 
 
3. Characterization of recombinat transferases activity against natural and synthetic substrates.  The 
level of exoglycosidases activity will also be determined.  Synthetic substrates of pNP-glycosides 
or 4-methylumbellyferyl-glycosides and pyridylaminated natural oligosaccharide will be used.  
[Ref:  Procedures: See Appendix B for our past works] 
 
4. Development of experimental design for sialylated glycoprotein production.  Combination of 
metabolic engineering, co-expression of recombinant baculovirus with several transferases, sugar 
feeding will be used. The possibility of using of suitable β-N-acetylglucosaminidase inhibitor will 
also be explored.  Optimal condition for the expressions of recombinant therapeutic protein 
(human transferin as a substrate acceptor), transferases, sugar nucleotide(substrate donor) and 
other parameter will all be determined.  Statistical analyses (Response Surface Methodology and 
Taguchi Method) will be used to optimize the process. 
[Ref:  Ani,I., Ismail,A.F., Noordin,M.Y. and Shilton, S.J. (2002). Optimisation of cellulose acetate 
details of reverse osmosis hollow fibre membranes using Taguchi Methods. Journal of membrane 
Science, 5298, 1-15.] 
  
5. Large-scale glyprotein expression with the application of several parameters and its effect on 
oligosaccharide structure will be carried out. Purification of recombinant protein and its 
oligosaccharide characterization will be carried out.  [Ref:  Appendix B for related works] 
 
Table 1. Facilities and Equipment Required. 
 
1. High pH Anion Exchange Chromatography                      Available 
           
         2. High Performance Liquid Chromatography                       Available 
                                                              
         3.  Protein Chromatography Apparatus/Accessories            New  (to be acquired from this project)          
      (HPLC Columns, ion exchange resins, affinity resin 
       and fraction collector) 
 
 4.  2L bioreactor and cell culture facilities                              Available   
 
 5.  Vacuum Evaporator                                                          New  (to be acquired from this project) 
V. Research Approach 
B. Project activities (Please list and describe the main project activities, including those associated with the transfer of 
the research results to customers/beneficiaries.  The timing and duration of these activities are to be shown in the Gantt 
chart  in Form VI) 
1. The determination of optimal growth and product formation conditions.  These activities 
includes: 
i. The expression of necessary glycosyltransferases for effective glycosylation.  
Levels and specific activity of each enzyme will be evaluated. 
ii. Optimization experiments for sugar nucleotide expression in selected cell 
lines.  Optimal sugar concentration (N-acetylglucosamine, Galactose and 
Mannose and Mannosamine) will be determined. 
 
 
2. Development of experimental design for sialylated recombinant glycoprotein poduction.     
1-2L scale glyprotein expression with the application of several parameters and its effect 
on oligosaccharide structures will be carried out.  Optimal conditions for protein 
expression, sugar nucleotide level and the extent of glycosylation will be determined. 
 
3. System improvements, process modifications and optimization. 
 
i. Process modifications and optimization will be carried out based on results 
of part 2.  The extent of protein glycosylation of the purified protein will be 
determined using HPLC, capillary electrophoresis and mass 
spectrophotometer.   
ii. The use of chemical inhibitor in combination with metabolic engineering 
approach and the possible use of immobilized enzyme reactor will also be 
explored to increase the sialylation of the recombinant glycoproteins. 
 
C. Key milestones (Please list and describe the principal milestones of the project.  The timing of milestones is to be shown 
in the Gantt chart on Form VI.  A key milestone is reached when a significant phase in the project is concluded, e.g. completion 
of test, review, commissioning of equipment, etc) 
1. The determination of optimal growth and product formation conditions. 
 
2.  Development of the optimal processing conditions for human-like glycoprotein in an artificial system.
 
3. System improvements, process modifications and optimization. 
 
 
 
D. Risks of the project (Please describe factors the that may cause delays in, or prevent implementation of, the project as     
proposed above; estimate the degree of risk) 
 
  Factors: 
 
1. Protein purification and the 
characterization of 
oligosaccharide structure are 
relatively simple procedures 
but significant delays are 
possible under inexperienced 
hands 
 
 
 
 
      
 Low Medium High  
  Technical risk:   /    
        
  Timing risk:   /    
        
  Budget risk:   /    
        
E. Duration (State the planned starting date of the project and the elapsed time, in months,  to complete this project; 
technology transfer activities should be excluded from elapsed time) 
 
• Starting date                    January 2003 
 
 
 
• Duration/elapsed time     36 months 
 
 
 
  
 
 2003_ 2004_ 2005_ 200_ 200_ 
   Research  Activities J F M A M J J A S O N D J F M A M J J A S O N D S1 S2 S1 S2 S1 S2 
1. The determination of optimal     
growth and product formation 
conditions. 
 
 
/ 
 
 
/ 
 
 
/ 
 
 
/ 
 
 
/ 
 
 
/ 
 
 
/ 
 
 
/ 
 
 
   / 
 
 
  / •
  
 
 
                  
2. Development of the optimal 
processing conditions for 
human-like glycoprotein in an 
artificial system 
          
/ 
 
/ 
 
/ 
 
/ 
 
/ 
 
/ 
 
   / 
 
   / 
 
   / 
 
   /•
 
 
          
3. System improvements, process 
modifications and optimization 
             
 
 
 
 
 
 
 
 
   / 
 
   / 
 
   / 
 
   / 
 
   / 
 
   / 
 
   / 
 
   / 
 
   / 
    
   /•
    
                               
                        
 
       
.                               
                           
 
    
                               
                               
                               
 Technology Transfer Activities                               
1. Publications. Documentations 
and Patent Filing. 
                          
/• 
    
                               
 
 
• Planned milestone  
S1: First Semester 
S2: Second Semester  
  
 
VI. Project Schedule 
 
 
 
 
A. Staff costs (Please include the yearly staff costs of the project.  For computation, use the Staff Cost Estimation Form in Appendix D.  Numbers in parentheses refer to expense codes) 
 Staff Category Year 1 (2002/2003) Year 2 (2003/2004) Year 3 (2004/2005) Year 4 
( )
Year 5 
( )
Total  
 • Salaried personnel 
(11100) 
• Temporary and contract personnel 
(J 400) 
30240 
 
20000 
30240 
 
20000 
30240 
 
20000 
- 
 
- 
- 
 
- 
90720 
 
60,000 
 
 Sub-total staff costs 50240 50240 50240   150,720  
         
B. Direct project expense (Please include the yearly direct  expenses of the project.  For computation, use the Direct Expenses Estimation Form in Appendix E.  Numbers in parentheses 
refer to expensa codes) 
 Staff Category Year 1 (2002/2003) Year 2 (2003/2004) Year 3 (2004/2005) Year 4 
( )
Year 5 
( )
Total   
 • Travel and transportation (J500) 
• Rentals (J600) 
• Research material and supplies     
(J700) 
• Minor modifications and repair (J800) 
• Special services (J900) 
• Special equipment and accessories 
(J1000) 
7000 
3000 
28,000 
 
4000 
5000 
40000 
5000 
3000 
22,000 
 
4000 
3000 
0 
3000 
1000 
13000 
 
0 
3000 
0 
  15000 
7000 
63,000 
 
8000 
11000 
40000 
 
 Sub-total staff costs 87,000 37,000 20,000   144,000  
         
C. Total cost (Please add the sub-totals of A and B) 
  Year 1 (2002/2003) Year 2 (2003/2004) Year 3 (2004/2005) Year 4 
( )
Year 5 
( )
Total   
   
137,240 
 
87,240 
 
70,240 
   
294,720 
 
         
VII. Project Cost
 
 
 
 
 
 
 
 
 
 
 
A. Funding sources (Please indicate funding sources for the project; see list of funding sources in the Guidelines)  
  
Funding Sources 
 
RM 
 
% of Total Funding 
 
 
 
 
• IRPA Grant 
 
 
• Internal Funds 
 
 
• Other Sources (please specify) 
 
 
204,000 
 
 
90,720 
 
 
Nil 
 
 
69.2% 
 
 
30.8% 
 
 
Nil 
 
 Total 294,720 
 
100%  
     
B. Disbursement schedule for IRPA funds, by participating research organisation (Please indicate how IRPA funding for the project will be allocated) 
 Organisation Year 1 
(2002/2003) 
Year 2 
(2003/2004) 
Year 3 
(2004/2005) 
Year 4 
(………...) 
Year 5 
(………...) 
Total  
   
 
            UTM 
 
 
107,000 
 
 
57,000 
 
 
40,000 
   
 
    204,000 
 
 Total IRPA Grant 107,000 57,000 40,000        204,000  
         
VIII. Project Funding
 
 
 
  
 
  
 
A. Contractual obligations under this project (Please indicate any contractual obligations with third parties that 
will be entered in for this project) 
         None 
B. Ownership of intellectual property rights (Please indicate the organisation(s) that will own the intellectual 
property rights that may arise from this project) 
 
 
 
       UNIVERSITI TEKNOLOGI MALAYSIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. Approving Officer (of the organisation in which the Project Leader is based) 
 
 
 
Name :       
   
Designation :       
   
Date :   Signature :   
   
 
IX. Contractual Matters 
  
 
Please follow the following format when submitting the curriculum vitae of key research personnel 
A. Personal Data 
1. Name 
 
:  Dr Ani Idris  
2. IC No 
 
:  630202-71-5300 (A2257141)  
3. Date and Place of Birth 
 
:  2 February, 1963. Singapore  
4. Sex 
 
:  Female  
5. Nationality 
 
:  Malaysia  
6. Name of Current Employer 
 
:  Universiti Teknologi Malaysia  
7. Address 
 
:  Jabatan Kejuruteraan Bioproses 
Fakulti Kejuruteraan Kimia dan Kejuruteraan Sumber Asli 
Universiti Teknologi Malaysia 
Karung Berkunci 791 
80990 Johor Bahru 
Johor 
 
 
8. Telephone No 
 
:  07-5576160 ext. 5403  
9. Fax No 
 
:  07-5581463  
10. Title of Position Held 
 
:  Lecturer  
11 Signature of Researcher :  25/6/2002  
 
12. 
 
Date 
 
: 
   
      
B. Educational Qualifications 
1. 
 
i. 
 
 
 
 
 
 
 
 
ii. 
 
 
 
 
 
 
Academic Qualification 
 
Degree 
 
Field 
 
Year 
 
Name and Place of Institution 
 
 
Degree 
 
Field 
 
Year 
 
Name and Place of Institution 
 
 
: 
 
: 
 
: 
 
: 
 
: 
 
: 
 
: 
 
: 
  
 
Ph.D Bioproses Engineering 
 
Membrane Technology 
 
2002 
 
Universiti Teknologi Malaysia 
 
 
MSc. in Biochemical Engineering 
 
Biochemical Engineering 
 
1989 
 
University College London 
United Kingdom 
 
 
 
 
 
 
 
 
Appendix A – Curriculum Vitae 
  
 
 
iii. 
 
Degree 
 
Field 
 
Year 
 
Name and Place of Institution 
 
: 
 
: 
 
: 
 
: 
 
  
BSc. in Chemical Engineering 
 
Chemical Engineering 
 
1988 
 
Universiti Teknologi Malaysia 
 
      
C. Research Experience 
1. Number of Years of 
Experience in the Field 
Related to the Proposed 
Project 
 
:  4 years  
2. Fields of Specialisation 
 
:  Membrane Manufacturing Technology 
Reverse Osmosis Separation Technology/Systems 
Ultrafiltration Separation Systems 
 
3. 
 
 
 
1. 
Major Research 
Programmes/Projects 
Completed 
 
Title 
 
From 
 
To 
 
Position held 
 
Major output 
 
(Repeat as necessary) 
 
 
 
 
 
: 
 
: 
 
: 
 
: 
 
: 
 
  
 
 
 
Development of Hollow Fiber Membranes 
 
4/99  
 
5/2001 
 
 
Principal Researcher 
 
Spinning rig has been fabricated, set up, improved and 
improvised and operated locally. A reverse osmosis test rig has 
been designed and also fabricated. Locally made membranes 
has been manufactured and tested. 
 
12 technical papers has been published. 
 
 
 
2. 
 
 
 
 
 
 
 
 
 
 
 
 
Title 
 
From 
 
To 
 
Position held 
 
Major output 
 
 
 
 
 
: 
 
: 
 
: 
 
: 
 
: 
 
 
 
: 
 Production and testing of ultrafiltration membranes 
 
12/99 
 
12/2001 
 
Project leader /researcher 
 
Locally made UF membranes has been produced and tested. A 
UF test rig has been designed and also fabricated. 
 
2 technical papers has been published 
 
 
 
 
 
  
 
 
 
3. 
 
 
 
 
Title 
 
 
 
From 
 
To 
 
Position held 
 
Major output 
 
 
 
 
 
: 
 
 
 
: 
 
: 
 
: 
 
: 
 
  
 
Model development for characterization of ultrafiltration and 
Reverse osmosis membranes hollow fiber membranes 
 
1/3/02/2002 
 
28/02/2003 
 
Project leader 
 
 
In progress. 
 
 
 
4. 
 
 
 
 
 
 
 
 
 
 
 
5. 
 
 
 
 
 
 
 
 
 
 
6. 
 
 
 
 
 
 
 
 
 
 
7. 
 
Title 
 
From 
 
To 
 
Position held 
 
Major output 
 
 
 
 
Title 
 
From 
 
To 
 
Position held 
 
Major output 
 
 
 
Title 
 
From 
 
To 
 
Position held 
 
Major output 
 
 
Title 
 
From 
 
To 
 
Position held 
 
Major output 
: 
 
: 
 
: 
 
: 
 
: 
 
 
 
: 
 
: 
 
: 
 
: 
 
: 
 Thermal Energy   Storage 
 
 
   10/94 
 
   11/95 
 
Project leader /researcher 
 
Spiral wound heat exchanger has been designed 
 
Pilot scale   production of efficient   techniques for    
deodorisation of cocoa butter 
 
3/96 
 
11/98 
Researcher 
 
1 MSc Student 
 
 
Biodegration of lubricants /oil wastes from industries 
 
3/93 
 
 8/95 
 
Researcher 
 
1 MSc. Student 
 
Alternative Fuel for diesel from vegetable oil 
 
 3/92 
 
 8/93 
 
Researcher 
 
1 technical paper 
 
 
 
 
 
 
 
 
 
  
 
 
D. Research Achievements 
1. Honours and Awards 
 
:    
2. Major Publications 
 
:  Presented and published in International Journals and 
Conference Proceeedings. List as publications as attached 
overleaf.  
 
3. Number of Patents 
 
:  None  
4. Major Commercial 
Achievements 
 
:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
None.  
      
 
 
  
 
A. Project title 
 
         Evaluation of the Enzymes in the N-Glycosylation Pathways of Native and Genetically Engineered Insect Cells  
B. Relevance to proposed project 
 
         The proposed project will be a continuation of this project.  Some stably transformed cell lines and baculoviruses 
carrying the genes for human transferin, (model protein), α(2-6) sialyltransferase and β-1-4 galactosyltransferase 
are available (Gifts from Prof. Dr. Michael J. Betenbaugh of the Department of Chemical Engineering, Johns 
Hopkins University, Maryland, USA). 
C. Organisation(s) that were involved in the project (Please indicate the organisation that led the project) 
        Department of Biology & Department of Chemical Engineering, The Johns Hopkins   University, Baltimore, 
Maryland, USA. 
D. Names of senior staff  
• Programme head:  
• Project leader: Prof. Dr. Michael J. Betenbaugh 
• Key researchers: Prof. Dr. Yuan Chuan Lee 
Badarulhisam Abdul-Rahman, PhD 
Shawn Lawrence, PhD 
 
  
E. Description of the project (Please indicate project customers/beneficiaries, research approach adopted and outputs) 
 
The work is centered on the development of metabolic engineering approach to mimic human glycorprotein biosynthesis 
pathways in insect cell culture.  Missing genes in cell lines were determined.  By using human genome (NCBI) and 
Drosophila genome (FlyBASE) databases, human and Drosophila transferases genes were incorporated into suitable 
cell lines and used for the expression of human transferin, a model human glycoprotein.  Human transferin was chosen 
for its simple biantennary oligosaccharide structure with terminal sialic acid. 
The outputs of the project are two PhD dissertation and total 8 peer-reviewed papers are expected from the project. 
  
1.  N-glycan Patterns of Human Transferrin Produced in Trichoplusia ni Insect Cells: Effect of mammalian β(1-4)galactosyltransferase.  Journal of 
Glycobiology vol 10, no 8 pp 837-847, 2000. 
2.  Crocus sativus Lectin Recognizes Man3GlcNAc in the N-glycan Core Structure.  Journal of Biological Chemistry, vol 275, 35 Sept 1, pp 26772-
26779, 2000. 
3.  Application of Lanthanide Fluorescence in Glycobiology.  Journal of Glycobiology,  vol 10,no 10, 2000, pp 1140 
4.  β-1,4-Galactosyltransferase Activity in Native and Engineered Insect Cells Measured with Time-Resolved Eu3+-Fluorescence.  Journal of 
Carbohydrate Research Sept 2002-In Press 
5.  Expression of the human N-acetylneuraminic acid phosphate synthase gene with 2-keto-3-deoxy-D-glycero-D-galacto-nonionic acid biosynthetic 
ability. J Biol Chem 275 (23): 17869-77.   
6.  Determination of nucleotides and sugar nucleotide involved in protein glycosylation by high-performance anion-exchange chromatography: sugar 
nucleotide contents in cultured insect cells and mammalian cells.  Anal Biochem 293(1): 129-37, 2001. 
7.  Cloning, Expression and Characterization of Drosophilla melanogaster β-N-Acetylglucosaminidases.  (Manuscript: in preparation). 
8.  Exoglycosidases in Native and Genetically Engineered Trichoplusia ni, Snyder S2 and Sf9 Cell Lines- Activity towards natural and synthetic 
substrates. (Manuscript: in preparation). 
 
 
 
 
 
 
 
 
 
Appendix B – Summary of Relevant Past Research 
  
 
 
Role in Project 
Total Project Leader Researchers Support Staff Contract Staff 
Daily Rate (RM)  200 200 65 70 
Research Activities Man-Days1 
1. Expression of necessary 
glycosyltransferases. 
2. Characterization of enzymatic 
activity in transformed and 
baculovirus infected cells 
3. Optimisation experiment for 
sugar nucleotide concentration 
 
267 
 
165 
 
72 
 
25 
 
15 
 
8 
 
42 
 
20 
 
10 
 
50 
 
30 
 
16 
          
         150 
 
          100 
 
           36 
Total Year 1 (2003) Man-days 504 48 72 96 286 
Total Year 1 (2003) Cost (RM)2 50240 9600  14400 6240 20,000 
  (11100) (11100) (11100) (J 400) 
4. Development of experimental 
design for sialylated 
glycoprotein production 
 
5. Evaluation of processing 
parameters. 
6.  Optimisation of protein 
expression and glycosylation 
 
7. System improvements, process 
modifications and optimization 
8. Data collection and analysis 
9. Publications. 
 
 
115 
 
 
62 
 
 
141 
 
90 
 
78 
18 
 
 
 
5 
 
 
10 
 
 
10 
 
10 
 
5 
8 
 
 
10 
 
 
27 
 
 
15 
 
            10 
 
5 
5 
 
20 
 
 
0 
 
 
56 
 
10 
 
10 
0 
 
 
 
80 
 
 
25 
 
 
60 
 
60 
 
58 
3 
 
Total Year 2 (2004) Man-days 504 48 72 96 286 
Total Year 2 (2004) Cost (RM)2 50240 9600 14400 6240 20,000 
  (11100) (11100) (11100) (J 400) 
 
6(cont).  Optimisation of protein 
expression and glycosylation 
 
7(cont). System improvements, 
process  modifications and 
optimization.  
8.(cont). Data collection and analysis 
9(cont). Publications. 
 
223 
 
 
219 
 
 
46 
16 
 
15 
 
 
15 
 
 
10 
8 
 
30 
 
 
26 
 
 
8 
8 
 
48 
 
 
48 
 
 
0 
0 
 
130 
 
           
         130 
 
 
           28 
0 
Total Year 3 (2005) Man-days 504 48 72 96 286 
Total Year 3 (2005) Cost (RM)2 50240 9600 14400 6240 20,000 
  (11100) (11100) (11100) (J 400) 
      
Total Project Man-days 1506 144 216 288 858 
Total Project Staff Cost (RM) 151200 28800 43200 18720 60,000 
  (11100) (11100) (11100) (J 400) 
Total Man-months3 62.75 6 9 12 35.75 
 
Notes 
1. For each research activity, estimate the man-days required by each staff category. 
2. Compute the staff cost for each year by multiplying the total man-day by the daily rate of the corresponding staff category.  For daily 
rate computation, refer to the Guidelines. 
3. Compute the total man-months required for the project by dividing the total project man-days by 24. 
Numbers in parentheses are expense codes as shown in Form VII. 
 
 
 
 
 
 
 
 
APPENDIX C – Staff Cost Estimation Worksheet
  
 
 
Appendix D - Direct Expenses Estimation Worksheet    
        
         
    Exp           
  Expense Categories and Items  Code
Total 
RM 2003 2004 2005 2006 
  Travel and transportation J500 15,000 7,000 5,000 3,000 0 
1 Seminar/workshop/conference   7,000 3,000 2,000 2,000   
2 Short courses for technology updates   4,000 2,000 1,000 1000   
3 Travelling to collaborators overseas   4,000 2,000 2,000     
  Rentals J600 7,000 3,000 3,000 1,000 0 
1 Analytical equipment   5,000 2,000 2,000 800   
2 Others   2,000 1,000 1,000 200   
                
  Research materials and supplies J700 63,000 28,000 22,00 13,000 0 
1 Culture Media, serum, antibiotics and  standard oligosaccharides   22,700 10,000 10,800 1,900   
2 
Analytical Chemicals and Digestion Enzymes
(aminopyridine, 4MU-glycosides, PNG-F 
galactosidase, sialidase, Glucosaminidase 
etc) 
  35,900 15,900 10,000 10,000   
3 Communication   400 100 200 100   
4 Books, journals   2,000 1,000 500 500   
5 Others   2,000 1,000 500 500   
  Minor modifications and repairs J800 8,000 4,000 4,000 0 0 
1 Modification of fluorescence detector   4,000 2,000 2,000     
2 Recalibrate, service & minor repair of   4,000 2,000 2,000     
   existing equipments.             
  Special services J900 11,000 5,000 3,000 3,000 0 
1 Overseas expert advisers   9,000 5,000 3,000 1,000   
2 Filing of patents   1,000     1,000   
3 Exhibition & competition   1,000   . 1,000   
  Special equipment and accessories* J1000 40,000 40,000 0 0 0 
1 Protein chromatography acessories   25,000 25,000       
2 Vacuum evaporator   15,000 15,000       
  Total direct expenses   144,000 87,000 37,000 20,000 0 
        
        
* If major equipment, please provide description on page 2 of this appendix.    
        
        
        
 
 
 
 
 
  
 
Special Equipment and Accessories  (please describe and provide justification for major purchases) 
 
1. Description 
       Protein Chromatography Apparatus/Accessories 
       (HPLC Columns, ion exchange resins, affinity resin and fraction collector). 
 
2. Justification 
These accessories are important in the purification of recombinant proteins works. 
 
3. Estimated Cost 
RM 25,000 
Special Equipment and Accessories (please describe and provide justification for major purchases) 
 
 
1. Description 
Vacuum evaporator 
 
2. Justification 
Vacuum evaporator used to vaporize acidic sample quickly and this step is essential during the preparation of 
sample for analysis.  
 
3. Estimated Cost 
RM 15,000 
 
 
 
Special Equipment and Accessories (please describe and provide justification for major purchases) 
 
 
1. Justification 
 
 
2. Estimated Cost 
 
 
3. Description 
 
 
 
 
